Smoking and COPD-Mechanisms and Prevention

REFERENCES

• Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153(5)1530–1535
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson J A, Nilsson P M, Löfdahl C G. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98
   PubMed Web of Science ®Google Scholar
• Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2002; 166(3)329–332
   PubMed Web of Science ®Google Scholar
• de Marco R, Accordini S, Cerveri I, Corsico A, Antó J M, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P, Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J, Leynaert B, Neukirch F, Schouten J P, Wjst M, Burney P. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007; 175(1)32–39
   PubMed Web of Science ®Google Scholar
• Hukkinen M, Korhonen T, Broms U, Koskenvuo M, Kaprio J. Long term smoking behavior patterns predicting self-reported chronic bronchitis. COPD 2009, this issue
   PubMedGoogle Scholar
• Kaprio J. Genetic epidemiology of smoking behavior and nicotine dependence. COPD. COPD 2009, this issue
   Google Scholar
• Berrettini W. Nicotine addiction. Am J Psych 2008; 165(9)1089–1092
   PubMed Web of Science ®Google Scholar
• West R. The multiple facets of cigarette addiction and what they mean for encouraging and helping smokers to stop. COPD 2009, this issue
   PubMedGoogle Scholar
• Berlin I. Therapeutic strategies to optimize the effectiveness of nicotine replacement therapies. COPD 2009, this issue
   PubMedGoogle Scholar
• Buist A S, McBurnie M A, Vollmer W M, Gillespie S, Burney P, Mannino D M, Menezes A M, Sullivan S D, Lee T A, Weiss K B, Jensen R L, Marks G B, Gulsvik A, Nizankowska-Mogilnicka E, BOLD. Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370(9589)741–750
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson L G. Eva Rönmark. 20-year follow-up of a population study based COPD cohort—Report from the Obstructive Lung Disease in Northern Sweden Studies. COPD 2009, This issue
   PubMedGoogle Scholar
• Laitinen T, Hodgson U, Kupiainen H, Tammiletho L, Haahtela T, Kilpeläinen M, Lindqvist A, Kinnula V. Real world clinical data identifies gender related profiles in chronic obstructive pulmonary disease. COPD 2009, this issue
   PubMedGoogle Scholar
• Fabbri L M, Rabe K F. From COPD to chronic systemic inflammatory syndrome? From COPD to chronic systemic inflammatory syndrome?. Lancet 2007; 370(9589)797–799
   PubMed Web of Science ®Google Scholar
• Margretardottir O B, Thorleifsson S J, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist A S, Gislason T. Hypertension, systemic inflammation and body weight in relation to lung function impairment—an epidemiological study. COPD 2009, this issue
   PubMedGoogle Scholar
• Koli K, Hyytiäinen M, Ryynänen M J, Keski-Oja J. Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts. Exp Cell Res Nov 1, 2005; 310(2)370–382
   PubMed Web of Science ®Google Scholar
• Koli K, Myllärniemi M, Keski-Oja J, Kinnula V L. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008; 10(2)333–342, Review
   PubMed Web of Science ®Google Scholar
• Leppäranta O, Myllarniemi M, Salmenkivi K, Kinnula V L, eski-Oja J, Koli K. Reduce phosphorylation of the TGF-β signal transducer Smad2 in emphysematous human lung. COPD 2009, this issue
   PubMedGoogle Scholar
• Van Pottelbelge G R, Bracke K R, Joos G F, Brusselle G G. The role of dendritic cells in the pathogenesis of COPD: Liaison officers in the frontline. COPD 2009, this issue
   Google Scholar
• Tsoumakidou M, Demedts I K, Brusselle G G, Jeffery P K. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am J Respir Crit Care Med 2008; 177(11)1180–1186
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yao H, Rahman I. Current perspectives on role of chromatin modifications and deacetylases in COPD. COPD 2009, this issue
   PubMedGoogle Scholar
• Rajendrasozhan S, Yang S R, Kinnula V L, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(8)861–870
   PubMed Web of Science ®Google Scholar
• Kinnula V L, Crapo J D. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003; 167(12)1600–1619
   PubMed Web of Science ®Google Scholar
• Oberley-Deegan R E, Regan E A, Kinnula V L, Crapo J D. Extracellular Superoxide Dismutase and Risk of COPD. COPD 2009, this issue
   PubMedGoogle Scholar
• Louhelainen N, Myllarniemi M, Rahman I, Kinnula V L. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease. Int J COPD 2008; 3(4)585–603
   Google Scholar
• Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllärniemi M, Kinnula V L. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 2008; 7(12)5125–5132
   PubMed Web of Science ®Google Scholar
• Nicholas B, Skipp P, Mould R, Rennard S, Davies D E, O'Connor C D, Djukanovi R. Shotgun proteomic analysis of human-induced sputum. Proteomics 2006; 6(15)4390–4401
   PubMed Web of Science ®Google Scholar
• Casado B, Iadarola P, Pannell L K, Luisetti M, Corsico A, Ansaldo E, Ferrarotti I, Boschetto P, Baraniuk J N. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res 2007; 6(12)4615–4623
   PubMed Web of Science ®Google Scholar
• Gray R D, MacGregor G, Noble D, Imrie M, Dewar M, Boyd A C, Innes J A, Porteous D J, Greening A P. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med 2008; 178(5)444–452
   PubMed Web of Science ®Google Scholar
• Kipnis E, Hansen K, Sawa T, Moriyama K, Zurawel A, Ishizaka A, Wiener-Kronish J. Proteomic analysis of undiluted lung epithelial lining fluid. Chest 2008; 134(2)338–345
   PubMed Web of Science ®Google Scholar
• Nicholas B, O'Connor C D, Djukanovic R. From proteomisc to prescription–the search for COPD biomarkers. COPD 2009, this issue
   PubMedGoogle Scholar